Blueprint Medicines Statistics
Total Valuation
FRA:KA8 has a market cap or net worth of EUR 15.83 million. The enterprise value is 15.27 million.
Market Cap | 15.83M |
Enterprise Value | 15.27M |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
Earnings Date | Aug 29, 2025 |
Ex-Dividend Date | Jun 18, 2025 |
Share Statistics
Current Share Class | 4.83M |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +0.18% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.49M |
Valuation Ratios
The trailing PE ratio is 27.01.
PE Ratio | 27.01 |
Forward PE | n/a |
PS Ratio | 0.82 |
PB Ratio | 4.62 |
P/TBV Ratio | 6.84 |
P/FCF Ratio | 5.59 |
P/OCF Ratio | 5.35 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.85, with an EV/FCF ratio of 5.39.
EV / Earnings | 26.05 |
EV / Sales | 0.79 |
EV / EBITDA | 7.85 |
EV / EBIT | 11.95 |
EV / FCF | 5.39 |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.11.
Current Ratio | 1.70 |
Quick Ratio | 1.35 |
Debt / Equity | 0.11 |
Debt / EBITDA | 0.19 |
Debt / FCF | 0.13 |
Interest Coverage | 41.23 |
Financial Efficiency
Return on equity (ROE) is 16.79% and return on invested capital (ROIC) is 17.96%.
Return on Equity (ROE) | 16.79% |
Return on Assets (ROA) | 8.93% |
Return on Invested Capital (ROIC) | 17.96% |
Return on Capital Employed (ROCE) | 26.64% |
Revenue Per Employee | 298,708 |
Profits Per Employee | 9,015 |
Employee Count | 65 |
Asset Turnover | 2.17 |
Inventory Turnover | 124.15 |
Taxes
In the past 12 months, FRA:KA8 has paid 686,000 in taxes.
Income Tax | 686,000 |
Effective Tax Rate | 53.93% |
Stock Price Statistics
The stock price has decreased by -10.27% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -10.27% |
50-Day Moving Average | 3.41 |
200-Day Moving Average | 3.59 |
Relative Strength Index (RSI) | 40.53 |
Average Volume (20 Days) | 5,823 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:KA8 had revenue of EUR 19.42 million and earned 586,000 in profits. Earnings per share was 0.12.
Revenue | 19.42M |
Gross Profit | 12.03M |
Operating Income | 1.28M |
Pretax Income | 1.27M |
Net Income | 586,000 |
EBITDA | 1.95M |
EBIT | 1.28M |
Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 933,000 in cash and 375,000 in debt, giving a net cash position of 558,000.
Cash & Cash Equivalents | 933,000 |
Total Debt | 375,000 |
Net Cash | 558,000 |
Net Cash Per Share | n/a |
Equity (Book Value) | 3.42M |
Book Value Per Share | 0.71 |
Working Capital | 2.59M |
Cash Flow
In the last 12 months, operating cash flow was 2.96 million and capital expenditures -124,000, giving a free cash flow of 2.83 million.
Operating Cash Flow | 2.96M |
Capital Expenditures | -124,000 |
Free Cash Flow | 2.83M |
FCF Per Share | n/a |
Margins
Gross margin is 61.95%, with operating and profit margins of 6.58% and 3.02%.
Gross Margin | 61.95% |
Operating Margin | 6.58% |
Pretax Margin | 6.55% |
Profit Margin | 3.02% |
EBITDA Margin | 10.02% |
EBIT Margin | 6.58% |
FCF Margin | 14.59% |
Dividends & Yields
This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 4.57%.
Dividend Per Share | 0.15 |
Dividend Yield | 4.57% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 123.51% |
Buyback Yield | n/a |
Shareholder Yield | 4.52% |
Earnings Yield | 3.70% |
FCF Yield | 17.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
FRA:KA8 has an Altman Z-Score of 4.97 and a Piotroski F-Score of 7.
Altman Z-Score | 4.97 |
Piotroski F-Score | 7 |